Albany, NY -- (SBWIRE) -- 04/05/2017 -- Viral inactivation is one of the important steps in the manufacturing of biological products to inactivate the potential contaminant viruses. It renders the viruses inactive, or unable to infect. In the process, the surface chemistry of the virus is altered by inactivating the lipid or protein coating of virus. These biological products are used for the treatment and diagnostic purposes in humans.

One of latest trends in the viral inactivation market is onset of ultraviolet irradiation technology systems. The lifecycle and reproduction process of viruses can be altered by exposure to specific wavelengths of ultraviolet light. Rapid growth in biotechnological and pharmaceutical industries, high incidences of chronic diseases leading to vigorous new drugs launches, and strong R&D investments in the health care industry are factors which drive the viral inactivation market considerably. The high degree of consolidation is accounted as the obstruction in the viral inactivation market.

Obtain Report Details: http://www.transparencymarketresearch.com/viral-inactivation-market.html

Globally, the viral inactivation market is segmented based on product, method, end-user, application, and geography. By method, the market is divided into pasteurization, solvent detergent method, and other methods including ultraviolet irradiation, high-energy light, and microwave heating. The solvent detergent method segment held a large share of the global viral inactivation market in 2015, which is attributed to its lesser cost for capital infrastructure and its operational flexibility. The major reason for the significant market share of this segment is 100% viral death achieved by this process.

With respect to application, the market is segmented into stem cell products, vaccines and therapeutics, blood and blood products, cellular culture and gene therapy products, and tissue and tissue cultures. The vaccines and therapeutics segment dominated the market in 2015 with a significantly high share. By end-user, the market is segmented into academic institutes, pharmaceutical companies, contract research organizations, and other end-users. Other end-users primarily include various laboratories such as microbiology, immunology, molecular and stem cell culture laboratories, cell banks, and animal facilities. The product segment is divided into services, kits, reagents, and viral inactivation accessories.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21497

Geographically, the viral inactivation market is segmented into North America, Europe, Asia Pacific, and rest of the world.

Key players in the viral inactivation market are Parker Hannifin, Clean Cells, Merck KGaA, Charles River Laboratories International, Inc., Danaher Corporation, Rad Source Technologies, Sartorius AG, SGS S.A., and Texcel, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/